DEXWireNews

LPCN - UP 44% YTD - Bullish Momentum Still Moving

Long
NASDAQ:LPCN   Lipocine Inc.
Lipocine, Inc. operates as a pharmaceutical company, which engages in the research and development of treatment for use in men's and women's health through proprietary drug delivery technologies. It focuses on the oral testosterone replacement therapy and preterm birth prevention. The company was founded in 2011 and is headquartered in Salt Lake City, UT.

P/E Current
-3.48

P/E Ratio (with extraordinary items)
-3.79

SHORT INTEREST
54.12K 07/15/19

Average Recommendation: BUY

Average Target Price: 5.67

⭐⭐⭐ Sign Up for Free ⭐⭐⭐

1) Download our Mobile App >> link-to.app/dexwirenews

2) Join our Telegram >> t.me/DEXWireNews

3) Join us on WhatsApp >> dexwirenews.com/WhatsApp

4) Follow @DEXWireNews on Social Media
Clause de non-responsabilité

Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.